Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06018844 · ClinicalTrials.gov registry record

Novel mHealth Physical Activity Intervention for Youth With Type 1 Diabetes Mellitus

A clinical trial, sponsored by Children's Mercy Hospital Kansas City.

Terminated
Registry status
1
Enrollment target

NCT06018844: Clinical Trial study, sponsored by Children's Mercy Hospital Kansas City.

NCT06018844 is a clinical trial that was terminated before completion, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06018844 was terminated before completion, sponsored by Children's Mercy Hospital Kansas City.

TERMINATED
Registry status
1 participants
Enrollment target

Study Summary

The goal of this longitudinal cohort study is to learn about a mHealth intervention in Type 1 Diabetes (T1D) The main question\[s\] it aims to answer are: * Does the intervention increase the amount of text messages between the mHealth software and participants? * Do the text messages from the Nudge software increase moderate to vigorous physical activity (MVPA) in participants? * Does the MVPA encouraged by the Nudge software improve the HbA1c levels of participants? Participants will: * Receive text messages from the Nudge software * Report physical activity goals via the text messages to the Nudge software * Wear both an accelerometer and an actigraph for three weeks (spread out across the beginning, 30 days, and 90 days of participation) * Complete surveys at the beginning of participation * Complete daily surveys while wearing the devices * Complete surveys at the end of participation * Record physical activity in study surveys

Primary Outcome

percent of daily text messages exchanged between youth and the NUDGE bot

Interventions

  • OTHER NUDGE

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2024-07-25
Est. Completion 2025-06-26

Why NCT06018844 stopped before completion

NCT06018844 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which NUDGE is the first listed.

NCT06018844 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06018844 about?

NCT06018844 is a clinical study titled "Novel mHealth Physical Activity Intervention for Youth With Type 1 Diabetes Mellitus". The goal of this longitudinal cohort study is to learn about a mHealth intervention in Type 1 Diabetes (T1D) The main question\[s\] it aims to answer are: * Does the intervention increase the amount of text messages between the mHealth software and participants? * Do the text messages from the Nud...

What is the current status of trial NCT06018844?

This trial is currently terminated. The enrollment target is 1 participants. The study started on 2024-07-25. Estimated completion is 2025-06-26.

What interventions are being tested in trial NCT06018844?

The interventions under investigation include: NUDGE (OTHER).

Who is sponsoring clinical trial NCT06018844?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06018844, the US trial registry maintained by the National Library of Medicine. NCT06018844 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.